POSC18 The Real-World Clinical Effectiveness of GLP-1 Receptor Agonist Liraglutide Among Patients with Type 2 Diabetes in China: Based on Existing Healthcare Data
Abstract
Authors
L L.I.U. J Zhang N Zhang R Zhen X He
L L.I.U. J Zhang N Zhang R Zhen X He
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now